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extensive in adult patients with IPAH. The inﬂuence of these changes
on the development of PAH and on the outcome of this condition
deserves further study.
GW26-e2948
The Application of Intravascular Ultrasound to Evaluate Pulmonary
Vascular Properties and Predict Mortality in Pulmonary Arterial
Hypertension
Zongye Cai,1 Jun Pu,1 Ling-yue Sun,1 Cheng-de Yang,2 Ben He,1
Jieyan Shen1
1Department of Cardiology, Renji Hospital, Shanghai Jiaotong
University School of Medicine; 2Department of Rheumatology, Renji
Hospital, Shanghai Jiaotong University School of Medicine
OBJECTIVES We aimed to explore the application of intravascular
ultrasound (IVUS) to evaluate pulmonary vascular properties (PVPs)
and predict mortality in pulmonary arterial hypertension (PAH).
METHODS Patients (n¼51) with a systolic pulmonary arterial pressure
(SPAP) S40mmHg based on echocardiography were prospectively
enrolled. After underwent right heart catheterization (RHC) and IVUS, they
weredivided into 3 groups: PAHassociatedwith connective tissuediseases
(PAH-CTD) group (group1, n¼25), PAH due to other causes group (group2,
n¼15), and CTDs patients without PH (group3, n¼11). PAH group (groups 1
and 2) was divided into distal and proximal remodeling subtype based on
IVUS results. All patients were followed-up to compare the differences
among clinical variables, PVPs and survival rates.
RESULTS A total of 408 segments of pulmonary vessels were studied.
PAH group demonstrated a greater mean wall thickness (MWT)
(0.300.02, 0.330.02 vs. 0.210.02 mm, P<0.01) and a higher per-
centage of MWT (WTP) (13.62 0.59, 14.390.77 vs. 9.570.97%,
P<0.01) than group 3. Additionally, the pulmonary vascular me-
chanical properties (PVMPs) in PAH group were found to be worse
than those in group 3, with reduced compliance (8.850.8210-2,
6.280.6510-2 vs. 41.595.0210-2 mm2/mmHg, P<0.01) and
distensibility (0.830.09, 0.550.06 vs. 3.160.38%/mmHg, P<0.01),
higher elastic modulus (EM) (169.2515.10, 253.0022.11 vs.
43.784.27 mmHg, P<0.01) and stiffness index b (4.190.41,
5.180.34 vs. 2.390.27, P<0.01). Furthermore, an inverse exponen-
tial association was found between PVMPs and hemodynamic abnor-
malities, with R2 ranging from 0.544 to 0.777 (P<0.001). There was no
difference between groups 1 and 2 in survival curves. However, the
distal remodeling subtype had a higher mortality (22.73%) than the
proximal remodeling subtype with a hazard ratio of 10.14 (95% con-
ﬁdence interval: 1.686–61.00, P<0.05).
CONCLUSIONS IVUS may be useful in assessment of PH by evaluating
PVPs and predicting mortality. PAH group demonstrated worse PVPs
than CTDs patients without PH. PAH-CTD patients had better PVMPs
than PAH-due to other causes. There was no difference between PAH
groups in survival curves. However, distal remodeling subtype had a
higher mortality than proximal remodeling subtype.
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OBJECTIVES To investigate the clinical value of detecting cardiac
troponin T (cTnT) and plasma lactate (lac) for risk stratiﬁcation and
prognosis evaluation in patients with acute pulmonary embolism
(APE).
METHODS From January 2013 to Desember 2014, a total of 89 patients
were diagnosed with APE. All patients with a diagnosis of APE
established by lung scan or spiral computed tomography (CT) and
conﬁrmed by pulmonary angiography if necessary. Plasma troponin T
and lactate levels were tested at presentation. We considered lactate
values greater than or equal to 2 mmol/L and troponin T values greater
than or equal to 0.10 ng/mL to be abnormal. 89 patients with
conﬁrmed APE were divided into three groups according to the levels
of troponin T and plasma lactate: Group1 (n ¼ 16): cTnT < 0.1 ng/ml
and lac < 2.0 mmol/L; Group 2 (n ¼ 35): cTnT  0.1ng/ml or lac 
2.0 mmol/L; Group3 (n ¼ 38): cTnT  0.1 ng/ml and lac  2.0 mmol/L.
Analysis of troponin T and plasma lactate elevated risk stratiﬁcation
in patients with APE’s relationship with clinical prognosis.RESULTS Of the 89 patients included in the study, the mean age was
67 years (SD 10.2 years) and 45 (50.6%) were women. Clinical harmful
events were death caused by pulmonary embolism and clinical dete-
rioration deﬁned as progression to thrombolytic therapy, vasoactive
drugs, mechanical ventilation, shock, or cardiopulmonary resuscita-
tion. Patients with clinical harmful events in group 1, group 2 and
group 3 were 0 (0%) case, 7 (20.0%) cases, 21 (55.3%) cases respec-
tively and a signiﬁcant difference was observed (P <0.01). In the
group of proceeding clinical harmful events there were signiﬁcant
differences in troponin T and plasma lactate levels (p <0.01). 5 pa-
tients (5.6%) died in group 3and 0 (0%) case died in group 1 and group
2. All patients underwent thrombolysis treatment in group 3, 10 (28.6)
patients underwent thrombolysis treatment in group 2, and all pa-
tients underwent routine anticoagulation.
CONCLUSIONS Combinational detection of troponin T and plasma
lactate has important value for early risk stratiﬁcation and prognosis
evaluation in patients with APE. Patients with pulmonary embolism
elevated troponin T and plasma lactate level are at high risk of death
and adverse outcome.
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OBJECTIVES Pulmonary arterial hypertension (PAH) is a female pre-
dominant disease. However, women have preserved right ventricle
function and better survival compared with men suffered from PAH.
This “sex paradox” indicates sex hormones may contribute signiﬁ-
cantly to the pathogenesis of PAH. We sought to assess the relation-
ship between serum concentration of sex hormone and hemodynamic
parameters in men with idiopathic PAH (IPAH).
METHODS In the observational study, we recruited 98 male IPAH
patients (mean  SD age, 4118 years), at Cardio-Pulmonary Circula-
tion center (Shanghai Pulmonary Hospital), from June 2008 to October
2014. The study included 85 age-matched healthy male control sub-
jects. Serum concentrations of estradiol (E2), testosterone (TT) and
progesterone (P) were measured using immunoassays, and the clin-
ical, functional, and hemodynamic compromises were collected at
enrollment.
RESULTS Compared with the healthy controls, serum E2 concentra-
tions were increased, and serum TT, P concentrations were decreased
in IPAH patients [E2: 153 (99-215) vs 121 (97-140) pmol/l, p ¼ 0.002; TT:
8.8 (4.6-21.0) vs 15.8 (12.0-19.5) pmol/l, p ¼ 0.007; P: 0.32 (0.22-0.43)
vs 0.48 (0.33-0.63) ng/ml, p < 0.001]. There were correlations between
P and HR, WHO functional class (FC), 6MWD, serum brain natriuretic
peptide, pericardial effusion, pulmonary vascular resistance and car-
diac output (all P<0.05). There were no correlations between E2 or TT
and the above parameters. At linear regression analysis, P was the
predictor most associated to WHO FC, 6MWD, PVR elevation and CO
reduction. Furthermore, P was only the independent predictor most
associated with PVR elevation after adjustment for age, BSA and WHO
FC by multivariate analysis (R2¼0.346, 95% IC: -15.635w-0.986,
P¼0.027).
CONCLUSIONS This work demonstrates serum P concentrations were
decreased in male IPAH patients. It’s an independent predictor for
PVR elevation and could estimate the severity of men with IPAH.
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OBJECTIVES Pulmonary arterial hypertension (PAH) is a syndrome
resulting from a restricted ﬂow through the pulmonary arterial cir-
culation, giving rise to increased pulmonary vascular resistance and
